Esperion Therapeutics, Inc.
Symbol: ESPR (NASDAQ)
1.62
▲ (7.28%) 0.110
Company Description:
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
Key Stats
- Today's Open: $1.55
- Today's High: $1.735
- Today's Low: $1.505
- Today's Volume: 6.23M
- Yesterday Close: $1.51
- Yesterday High: $1.579
- Yesterday Low: $1.4511
- Yesterday Volume: 5.17M
- Last Min Volume: 100
- Last Min High: $1.62
- Last Min Low: $1.62
- Last Min VWAP: $1.62
Company Profile
- Name: Esperion Therapeutics, Inc.
- Website: https://www.esperion.com
- Listed Date: 2013-06-26
- Location: ANN ARBOR, MI
- Market Status: Active
- CIK Number: 0001434868
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $299.28M
- Round Lot: 100
- Outstanding Shares: 198.20M
- Asset Type: CS
RECENT FILINGS FOR ESPR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-18 | 4 | View |
| 2025-07-18 | 4 | View |
| 2025-07-17 | 144 | View |
| 2025-07-17 | 144 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 3 | View |
| 2025-07-01 | 8-K | View |
| 2025-06-18 | 4 | View |
| 2025-06-18 | 4 | View |
| 2025-06-18 | 4 | View |
| 2025-06-17 | 144 | View |
| 2025-06-17 | 144 | View |
| 2025-06-17 | 144 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
| 2025-06-02 | 4 | View |
Latest News on ESPR